[go: up one dir, main page]

ATE176483T1 - Derivate des parathormons - Google Patents

Derivate des parathormons

Info

Publication number
ATE176483T1
ATE176483T1 AT93104500T AT93104500T ATE176483T1 AT E176483 T1 ATE176483 T1 AT E176483T1 AT 93104500 T AT93104500 T AT 93104500T AT 93104500 T AT93104500 T AT 93104500T AT E176483 T1 ATE176483 T1 AT E176483T1
Authority
AT
Austria
Prior art keywords
amino acid
acid residue
ser
derivatives
alpha
Prior art date
Application number
AT93104500T
Other languages
English (en)
Inventor
Tsunehiko Fukuda
Shizue Nakagawa
Shigehisa Taketomi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5029283A external-priority patent/JPH05320193A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE176483T1 publication Critical patent/ATE176483T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
AT93104500T 1992-03-19 1993-03-18 Derivate des parathormons ATE176483T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6351792 1992-03-19
JP5029283A JPH05320193A (ja) 1992-03-19 1993-02-18 副甲状腺ホルモン誘導体

Publications (1)

Publication Number Publication Date
ATE176483T1 true ATE176483T1 (de) 1999-02-15

Family

ID=26367457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93104500T ATE176483T1 (de) 1992-03-19 1993-03-18 Derivate des parathormons

Country Status (5)

Country Link
US (1) US5434246A (de)
EP (1) EP0561412B1 (de)
AT (1) ATE176483T1 (de)
CA (1) CA2091873C (de)
DE (1) DE69323337T2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4203040A1 (de) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US6110892A (en) * 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5955425A (en) * 1996-08-02 1999-09-21 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
AU4415796A (en) * 1994-12-07 1996-06-26 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5969095A (en) * 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
CA2290443A1 (en) * 1997-05-14 1998-11-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Peptide parathyroid hormone analogs
AU1447600A (en) 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
JP2002534081A (ja) 1998-12-31 2002-10-15 ザ ジェネラル ホスピタル コーポレーション Ｐｔｈレセプターおよびそれを使用するスクリーニングアッセイ
AU2486800A (en) * 1998-12-31 2000-07-31 General Hospital Corporation, The Pth functional domain conjugate peptides, derivatives thereof and novel tetheredligand-receptor molecules
US7057012B1 (en) 1998-12-31 2006-06-06 The General Hospital Corporation PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
US6988138B1 (en) * 1999-06-30 2006-01-17 Blackboard Inc. Internet-based education support system and methods
WO2001023521A2 (en) 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
EP2030986A1 (de) * 1999-09-29 2009-03-04 The General Hospital Corporation Polypeptidderivate des Parathyroidhormons (PTH)
US7022815B1 (en) 1999-09-29 2006-04-04 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (PTH)
CA2389850A1 (en) 1999-11-02 2001-05-10 Taraz' U' Llah Saba A gas valve
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
AU2002339843B2 (en) 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
EP1531855A4 (de) 2002-01-10 2009-07-22 Osteotrophin Llc Behandlung von knochenerkrankungen mit skelettalen anabolika
AU2003239869A1 (en) * 2002-05-23 2003-12-12 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
EP2201960A1 (de) 2003-03-19 2010-06-30 The General Hospital Corporation Konformationseingeschränkte Parathormone mit Alpha-Helix-Stabilisatoren
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
JP4871128B2 (ja) 2003-07-17 2012-02-08 ザ ジェネラル ホスピタル コーポレイション 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
WO2008019062A2 (en) 2006-08-04 2008-02-14 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
CA3017668C (en) 2007-08-01 2021-11-09 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
KR101900078B1 (ko) 2010-05-13 2018-09-18 더 제너럴 하스피탈 코포레이션 부갑상선 호르몬 아날로그 및 그의 용도
US20200354428A9 (en) 2013-06-23 2020-11-12 Wisconsin Alumni Research Foundation Analogues of parathyroid hormone (1-34) that function as agonists of the parathyroid hormone receptor-1 and display modified activity profiles
BR112022024058A2 (pt) * 2020-05-26 2022-12-20 Univ Indiana Res & Tech Corp Análogos de pth para o tratamento de hipoparatireoidismo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5039451B2 (de) * 1972-06-08 1975-12-17
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
US4968669A (en) * 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
CA2087190A1 (en) * 1990-07-13 1992-01-14 Fred E. Cohen Parathyroid hormone analogues modified at positions
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体

Also Published As

Publication number Publication date
CA2091873C (en) 2002-10-15
CA2091873A1 (en) 1993-09-20
DE69323337D1 (de) 1999-03-18
EP0561412B1 (de) 1999-02-03
DE69323337T2 (de) 1999-09-02
US5434246A (en) 1995-07-18
EP0561412A1 (de) 1993-09-22

Similar Documents

Publication Publication Date Title
ATE176483T1 (de) Derivate des parathormons
ATE172711T1 (de) 2-amino-1, 3- propandiolverbindung und immunosuppressium
IL100015A0 (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE86964T1 (de) Malonsaeurederivate und ihre synthesemethoden.
HK131596A (en) N-(3-hydroxy-4-piperidinyl) (dihydro-benzofuran dihydro-2h-benzopyran or dihydro-benzodioxin) carboxamide derivatives
ATE155486T1 (de) Zyklische peptide und ihre verwendung
EP0291234A3 (en) Peptidic human leukocyte elastase (hle) inhibitors
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
NO894602L (no) Farmasoeytisk blanding inneholdende n-(3,4-dimetoksy-cinnamoyl)antranilsyre.
IL139710A (en) Benzamide derivatives for the treatment of diseases mediated by cytokines
ES2096073T3 (es) Derivado de benzamida.
NZ234501A (en) Hemoregulatory peptides and pharmaceutical compositions containing them
DE69430295D1 (de) Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
NO894720D0 (no) Farmasoeytisk aktivt protein.
EP0821004A4 (de) Neue peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten
ES2166458T3 (es) Derivados nucleosidos de pirimidina.
DE3887611D1 (de) Butensäure-Amide, deren Salze, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties